This risk assessment focuses on the threat to the refugee population from communicable diseases and assesses the situation in Europe, associated with the current movements of refugees across the region and in the context of their living conditions and the approaching winter, access to shelter, sanitation and health services.
Early in 2015, a shortage of acellular pertussis-containing vaccines was brought to the attention of ECDC. This risk assessment provides a detailed list of mitigation options available to Member States.
ECDC and EFSA have assessed the risk to the EU/EEA posed by a fatal human case of Bacillus anthracis infection in Bulgaria and concluded that this event represents a negligible risk to other EU/EEA countries.
This rapid risk assessment concludes that there is currently no indication that these cases represent a significant outbreak of diphtheria among refugees in Europe.
The autochthonous transmission of Schistosoma haematobium in Corsica in 2013 was a local public health event that highlighted a potential risk for other parts of the EU.
The detection, management and public health response to the first case of diphtheria in Spain in nearly 30 years has highlighted challenges for preparedness against diphtheria in the European Union.
This rapid risk assessment reports on a multinational outbreak of Salmonella Enteritidis which is currently ongoing among junior ice hockey players who attended the Riga Cup 2015 in Latvia.
A large outbreak of Legionnaires’ disease was reported by Portuguese authorities on 7 November 2014. This rapid risk assessment focuses on the risk for the EU in relation to this event.
This joint rapid outbreak assessment from ECDC and EFSA assesses a cluster of monophasic Salmonella Typhimurium with an MLVA pattern previously unseen in the EU/EEA.